ARTICLE | Company News
StemPar, University of Illinois, University of Texas Southwestern Medical Center deal
January 14, 2013 8:00 AM UTC
The universities granted StemPar exclusive, worldwide rights to IP covering quinine-based compounds, including preclinical candidate SPS-201. The company plans to submit an IND next year for the smal...